Association Of-308G/A,-238G/A TNF-α Polymorphisms with Multiple Myeloma Risk and Survival: A Systematic Review and Meta-Analysis

被引:3
作者
Alymatiri, Christina M. [1 ]
Gkegka, Georgia T. [1 ]
Gavriatopoulou, Maria [1 ]
Terpos, Evangelos [1 ]
Dimopoulos, Meletios A. [1 ]
Sergentanis, Theodoros N. [1 ]
Psaltopoulou, Theodora [1 ]
机构
[1] Natl & Kapodistrian Univ Athens, Sch Med, Dept Clin Therapeut, Athens, Greece
关键词
Tumor necrosis factor alpha; Gene polymorphisms; Prognosis; Cytokines; Gene promoter; NECROSIS-FACTOR-ALPHA; GENE POLYMORPHISMS; PROMOTER POLYMORPHISMS; HAPLOTYPES; VARIANTS; DISEASE; THERAPY; REGION;
D O I
10.1016/j.clml.2021.08.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumor necrosis factor alpha (TNF-alpha) plays a key role in multiple diseases, including cancer. Eighteen studies were included in this systematic review and meta-analysis examining TNF-alpha polymorphisms in association with risk, and five studies in survival of multiple myeloma (MM). No association was found between -308G/A and -238G/A TNF-alpha polymorphisms and MM susceptibility or survival. Introduction: Tumor necrosis factor alpha (TNF-alpha) is a cytokine with a key role in proinflammation and multiple diseases, including cancer. The gene encoding TNF-alpha is located within a highly polymorphic region on chromosome 6p21.3; two polymorphisms -308G/A (rs1800629) and -238G/A (rs361525) have been associated with occurrence of human diseases. There is a debate in recent meta-analyses that reached discrepant conclusions regarding the potential role of TNF-alpha polymorphisms in multiple myeloma (MM) risk. The aim of this systematic review and meta-analysis is to investigate the association between the aforementioned two polymorphisms with the risk and survival of MM. Materials and methods: Eligible articles were identified through an extensive search in PubMed database (end of search: June 18, 2020). The pooled effect estimates were calculated following the random-effects models by Der Simonian and Laird. Separate analyses were conducted by ethnicity. Between-study heterogeneity was quantified, and the deviation of genotype frequencies in controls from the Hardy-Weinberg equilibrium was evaluated. Results: Eighteen studies (2934 cases, 4291 controls) have been included in the quantitative synthesis examining risk and 5 studies for survival (557 cases). No association was found between -308G/A and -238G/A TNF-alpha polymorphisms and MM susceptibility in all genetic models for both Caucasian and East Asian populations. There was no association between -308G/A and -238G/A TNF-alpha polymorphisms and survival (overall or progression-free) of MM. Conclusion: This systematic review and meta-analysis did not reveal a significant effect of -308G/A and -238G/A TNF-alpha polymorphisms upon risk or survival of MM. (C) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页码:E96 / E115
页数:20
相关论文
共 50 条
  • [1] ABRAHAM LJ, 1993, CLIN EXP IMMUNOL, V92, P14
  • [2] Multiple myeloma: A review of the epidemiologic literature
    Alexander, Dominik D.
    Mink, Pamela J.
    Adami, Hans-Olov
    Cole, Philip
    Mandel, Jack S.
    Oken, Martin M.
    Trichopoulos, Dimitrios
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2007, : 40 - 61
  • [3] [Anonymous], 2012, CHIN J CANC PREV TRE
  • [4] Tumor necrosis factor alpha promoter polymorphism and the risk of chronic lymphocytic leukemia and myeloma in the Chinese population
    Au, W. Y.
    Fung, A.
    Wong, K. F.
    Chan, C. H.
    Liang, R.
    [J]. LEUKEMIA & LYMPHOMA, 2006, 47 (10) : 2189 - 2193
  • [5] Basmaci C, 2016, Asian Pac J Cancer Prev, V17, P1009
  • [6] BORSET M, 1994, EUR J HAEMATOL, V53, P31
  • [7] Common variants in genes that mediate immunity and risk of multiple myeloma
    Brown, Elizabeth E.
    Lan, Qing
    Zheng, Tongzhang
    Zhang, Yawei
    Wang, Sophia S.
    Hoar-Zahm, Shelia
    Chanock, Stephen J.
    Rothman, Nathaniel
    Baris, Dalsu
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (12) : 2715 - 2722
  • [8] In silico analysis of single nucleotide polymorphism (SNP) in human TNF-alpha gene
    Dabhi, Brijesh
    Mistry, Kinnari N.
    [J]. META GENE, 2014, 2 : 586 - 595
  • [9] DALFONSO S, 1994, IMMUNOGENETICS, V39, P150
  • [10] High-producer haplotypes of tumor necrosis factor alpha and lymphotoxin alpha are associated with an increased risk of myeloma and have an improved progression-free survival after treatment
    Davies, FE
    Rollinson, SJ
    Rawstron, AC
    Roman, E
    Richards, S
    Drayson, M
    Child, JA
    Morgan, GJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (15) : 2843 - 2851